Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Oncology (Williston Park, N.Y.)|March 2, 2006
New treatments for multiple myelomaPaul G Richardson, Robert Schlossman, Teru Hideshima, et al.The Oncologist|July 3, 2007
New drugs for myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|April 18, 2008
Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jawsNathaniel S Treister, Paul Richardson, Robert Schlossman, et al.Clinical Lymphoma & Myeloma|October 20, 2005
Emerging trends in the clinical use of bortezomib in multiple myelomaPaul G Richardson, Robert Schlossman, Constantine Mitsiades, et al.Blood|October 24, 2002
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieuTeru Hideshima, Masaharu Akiyama, Toshiaki Hayashi, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell MalignanciesSteven P. Treon, Constantine Mitsiades, Nicholas Mitsiades, et al.Expert Review of Anticancer Therapy|July 1, 2008
Bortezomib in the front-line treatment of multiple myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.Core Evidence|August 10, 2010
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapyPaul Richardson, Constantine Mitsiades, Jacob Laubach, et al.Hematology. American Society of Hematology. Education Program|November 21, 2007
The treatment of relapsed and refractory multiple myelomaPaul Richardson, Constantine Mitsiades, Robert Schlossman, et al.Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs in multiple myelomaIrene M Ghobrial, Xavier Leleu, Evdoxia Hatjiharissi, et al.Pageof 5